Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?

被引：34

作者：

Chavda, Vivek P. ^{[1
]}

Apostolopoulos, Vasso ^{[2
,3
]}

机构：

[1] LM Coll Pharm, Dept Pharmaceut & Pharmaceut Technol, Ahmadabad 380008, Gujarat, India

[2] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic 3030, Australia

[3] Australian Inst Musculoskeletal Sci AIMSS, Immunol Program, Melbourne, Vic 3021, Australia

来源：

VACCINES | 2022年 / 10卷 / 03期

关键词：

Omicron variant; SARS-CoV-2; booster dose; vaccine;

D O I：

10.3390/vaccines10030367

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The Omicron variant of SARS-CoV-2 is emerging in communities where people were previously infected with SARS-CoV-2 and are now being vaccinated, or where many people have received two or three coronavirus vaccination doses. More than 130 countries around the globe have implemented booster dose programs for tackling omicron endemics. Despite early findings shows that booster doses may improve omicron protection, more research is needed to establish vaccination efficacy. This short communication tries to critically discuss the research work findings around booster dose strategy for omicron endemics.

引用

页数：6

共 50 条

[1] Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
Wei Zhang
Linfen Huang
Gang Ye
Qibin Geng
Nwando Ikeogu
Morgan Harris
Gayathri Dileepan
Kristina Burrack
Lanying Du
Anne Frosch
Fang Li
[J]. Cellular & Molecular Immunology, 2022, 19 : 445 - 446
[2] Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
Zhang, Wei
Huang, Linfen
Ye, Gang
Geng, Qibin
Ikeogu, Nwando
Harris, Morgan
Dileepan, Gayathri
Burrack, Kristina
Du, Lanying
Frosch, Anne
Li, Fang
[J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (03) : 445 - 446
[3] Modeling the SARS-CoV-2 Omicron variant dynamics in the United States with booster dose vaccination and waning immunity
Avila-Ponce de Leon, Ugo
Perez, Angel G. C.
Avila-Vales, Eric
[J]. MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2023, 20 (06) : 10909 - 10953
[4] Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
Lee, Byung Uk
[J]. AEROSOL AND AIR QUALITY RESEARCH, 2022, 22 (01)
[5] SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debate
Rizzo, Alessandro
Palmiotti, Gennaro
[J]. FUTURE ONCOLOGY, 2022, 18 (11) : 1301 - 1302
[6] Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
Kuhlmann, Constanze
Mayer, Carla Konstanze
Claassen, Mathilda
Maponga, Tongai
Burgers, Wendy A.
Keeton, Roanne
Riou, Catherine
Sutherland, Andrew D.
Suliman, Tasnim
Shaw, Megan L.
Preiser, Wolfgang
[J]. LANCET, 2022, 399 (10325): : 625 - 626
[7] Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection
Widyasari, Kristin
Jang, Jieun
Kang, Taejoon
Kim, Sunjoo
[J]. VIRUSES-BASEL, 2023, 15 (08):
[8] Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
Xiaoqi Yu
Dong Wei
Wenxin Xu
Yulong Li
Xinxin Li
Xinxin Zhang
Jieming Qu
Zhitao Yang
Erzhen Chen
[J]. Cell Discovery, 8
[9] mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Nanishi, Etsuro
McGrath, Marisa E.
O'Meara, Timothy R.
Barman, Soumik
Yu, Jingyou
Wan, Huahua
Dillen, Carly A.
Menon, Manisha
Seo, Hyuk-Soo
Song, Kijun
Xu, Andrew Z.
Sebastian, Luke
Brook, Byron
Bosco, Anna-Nicole
Borriello, Francesco
Ernst, Robert K.
Barouch, Dan H.
Dhe-Paganon, Sirano
Levy, Ofer
Frieman, Matthew B.
Dowling, David J.
[J]. COMMUNICATIONS BIOLOGY, 2022, 5 (01)
[10] Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
Yu, Xiaoqi
Wei, Dong
Xu, Wenxin
Li, Yulong
Li, Xinxin
Zhang, Xinxin
Qu, Jieming
Yang, Zhitao
Chen, Erzhen
[J]. CELL DISCOVERY, 2022, 8 (01)

← 1 2 3 4 5 →